Official Title
Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19
Brief Summary

Achieved serum samples of persons with or without evidence of COVID-19 infection are tested using the different commercial SARS-CoV-2 antibody immunoassays. The performance of the immunoassays is then assessed by comparing the 2 groups of samples.

Detailed Description

Achieved serum samples of the different testing groups are retrieved and tested with the
immunoassays according to manufacturer's instruction.

The test results are then compared and analyzed with statistical tests to assess the
immunoassays'performance

Unknown status
COVID19

Diagnostic Test: SARS-CoV-2 antibody immunoassays

Different commercial SARS-CoV-2 antibody immunoassays

Eligibility Criteria

Inclusion criteria for COVID-19 infected sera: any patient with PCR confirmed COVID-19
infection

Inclusion criteria for COVID-19 negative sera: sera collected after a negative SARS-CoV-2
PCR

Exclusion Criteria:

-

Eligibility Gender
All
Eligibility Age
Minimum: N/A ~ Maximum: N/A
Countries
Hong Kong
Locations

Hong Kong Sanatorium & Hospital
Hong Kong, Hong Kong

Jonpaul Sze Tsing Zee, MBChB, Principal Investigator
Hong Kong Sanatorium & Hospital

Hong Kong Sanatorium & Hospital
NCT Number
MeSH Terms
COVID-19
Antibodies